Capabilities
Our Digital Health group guides companies through the myriad considerations they encounter as the delivery of healthcare becomes increasingly digital.
As private equity investment in the Life Sciences and Healthcare industry continues to increase, our cohesive regulatory and transactional approach helps ensure success through each phase of investment.
We provide 360-degree support to companies that develop, manufacture and distribute products tailored specifically toward improving women’s health, from start-ups to global corporations.
Our Sunshine and State Law Compliance Group serves as a powerful industry advocate with respect to transparency laws for more than 100 members companies.
We established the Surprise Billing and Price Transparency Group to assist our clients in developing solutions to changes in healthcare transparency laws.
The K&S International Ad Hoc Group is a coalition of 20+ pharma and medical device companies that focuses on international transparency/disclosure laws targeting manufacturers.
March 26, 2025
Saudi Arabia Permits Foreign Investment in Pharmacies
March 19, 2025
France Adopts a Law Banning PFAS in Cosmetics, Textiles, and Waxing Products
January 21, 2025
Health Headlines January 21, 2025
March 10, 2025
Litigation and trial partner Eric White joins the firm’s Product Liability and Mass Torts practice group in Chicago
March 10, 2025
Litigation and Trial Lawyer Eric White Joins King & Spalding in Chicago
February 24, 2025
King & Spalding Secures Another Victory for Boehringer Ingelheim in Zantac-Related Retrial
December 5, 2024
Sage Secures $35 Million Series B Funding